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A B S T R A C T
Incontinentia pigmenti (IP) is a rare, inherited, multisystem genodermatosis. It is transmitted as an X-linked domi-
nant trait. The disorder is a consequence of mutations in the NEMO gene (Xq28) that completely abolish expression of the
NF-kappaB essential modulator. Here we present a female infant of healthy nonconsanguinous, young parents with a
clinically evident first phase of IP. PCR analysis of patient’s peripheral blood lymphocytes DNA was done for detection of
NEMO D4–10 deletion. Skin changes present at birth appertain to first inflammatory stage. However, a pathohistological
feature of the skin biopsy showed second phase of disease. Genetic testing of diseased child revealed D4–10 in NEMO
gene. However, the assumption that the female child has familial IP was rejected as PCR performed on the mother’s leu-
kocytes did not record the presence of the same mutation. Moreover, the existence of a healthy male infant of the same
mother as well as the lack of any phenotypic signs of the disease in other family members additionally support that IP
was not inherited, but it was a consequence of de novo NEMO gene mutation. In conclusion, here we describe a Croatian
female with clinical IP phenotype having de novo genomic rearrangements in the NEMO gene.
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Introduction
The familial Incontinentia pigmenti syndrome (IP) or
'classical’ incontinentia pigmenti (also called Bloch-Sulz-
berger syndrome, degenerative melanosis coria and Asboe
Hansen disease) is a rare multisystem genodermatosis
that segregates as an X inherited dominant condition,
usually lethal prenatally in males. In about 80% of pre-
sented cases, IP is characterized by a distinctive swirling
pattern of the skin, various congenital abnormalities and
malformations of the head and neck (microcephaly, op-
hthalmological defects), skeletal system (kyphoscoliosis,
hemivertebrae, and hard palate defects), hair, nails, eyes
and teeth1. About 25% of the patients have mental retar-
dation, slow motor development, spastic tetraplegia and
diplegia2–4
More than 95% of the reported cases are females5.
Survival of affected men is probably the result of the so-
matic mosaicism of the X chromosome, or an extra X
chromosome, or genetic heterogeneity, or less deleterious
mutations6. The IP gene (NEMO or IKK, inhibitor kappaB
kinase) localized on Xq28,7 encodes for the NF-kB essen-
tial modulator (the regulatory subunit of the IkB kinase
complex) which is indispensable for activation of NF-kB
transcription factor. When activated, NF-kB controls the
expression of multiple genes and protects cells against
TNFá-induced apoptosis. IP cells are highly sensitive to pro-
apoptotic signals8–10. The most common mutation respon-
sible for disease development is the 4–10 NEMO gene de-
letion which completely abolishes the expression of the
NF-kB essential modulator3,10,11.
Heterozygous females are gene carriers and have a
high frequency of spontaneous abortions.
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Early diagnosis of IP is based on the presence of ab-
normal skin pigmentation often present at birth. It ra-
rely appears after the first two months6. The cutaneous
lesions evolve through four stages: vesiculobullous, ve-
rrucous, hyperpigmentary, and atrophic stage. Their se-
quence can be irregular, their duration variable and they
can overlap. Earlier stages can also occur in utero and do
not progress after birth.
Here we present a case of a female infant of healthy
nonconsanguinous, young parents with a clinically evi-
dent first phase of IP, caused by de novo D4–10 deletion in
the NEMO gene.
Methods
To investigate the NEMO gene deletion (D4–10 exons,
PCR amplification of DNA from blood leukocytes was
performed using two pairs of primers. For the nonmutated
gene these were diagnostic F (5’AGGGCTTAGAGCGCC
TGGCTTA-3’) and JFT3R (5’-CTCGGAGACACAGGAA
CCA GCA-3’) which produced a fragment of 1186 bp and
diagnostic F and 5R NEMO (5’-CTGCCTTGAGGTTGT
CAACGGCTT-3’) which amplify the gene when deletion
is present (1039 bp). Amplification was performed for 30
cycles (denaturation – 1 min at 94°C, annealing – 1 min
at 66 °C, and elongation – 1 min at 72 °C). The PCR mix-
ture (10ml) contained 100 ng of genomic DNA, 1xPCR
buffer, 1U Taq DNA polymerase, 1.6 mM MgCl2, 0.67 mM
of each primer, and 0.2 mM dNTPs. PCR products (10ml)
were analysed on 1% agarose gel. The band sizes were
compared with ones obtained from DNA samples of known
female carriers and healthy female controls.
All patients’ samples and clinical details were ob-
tained upon receiving patients’ consent and the local eth-
ical-committee approval.
Results
A 3-week-old infant female from the second normal
pregnancy was presented to the Department of Derma-
tology with unusual light brown streaks and whorls with
vesicles on the skin of the left arm, trunk and left leg.
These changes have been present since birth. The history
indicated normal pregnancy and parents were healthy
nonsanguinous. The first child was a healthy 2-year-old
male child.
Additional cutaneous examination revealed linear ma-
cular hyperpigmentation and linear accumulations of
clear vesicles and tight papules, which confluate in some
areas. They were associated with smooth, red plaques, of
irregular location on the lower extremities, sides of the
trunk and around the perigenital region. The slight
hyperpigmentation followed the lines of Blaschko (Fig-
ure 1).
Routine physical examination revealed a child of nor-
mal stature without any stigma. She displayed normal
gross motor development. Associated congenital anoma-
lies, which are characteristic for IP, were not present. He-
matological analysis showed marked blood eosinophilia
(29%) and leukocytosis (10 ´ 109/L). The biochemical
analyses as well as the CT scan were under normal lim-
its. The brain ultrasound and ophthalmological findings
as well as the EEG examination were within physiologi-
cal limits. Blood samples were obtained for karyogram
and DNA analysis.
Pathohistological examination revealed the second
phase of the disease based on the findings of basketwave
hyperkeratosis and slight acanthosis with interepider-
mal invasion of eosinophils and whorls of keratinocytes
with scattered dyskeratotic cells. The basal cells showed
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Fig. 1. Clinical feature of infant girl suffering from IP: gluteal
and femoral region.
Fig. 2. High-power view of cutaneous IP lesion with characteristic
whorls of keratinocytes and eosinophils between epidermal cells;
(H&E; original magnification ´ 400).
vacuolisation. In dermis, a mild perivascular chronic in-
flammatory infiltrate was found. Collagen tissue was
normal. Leukocytosis and eosinophilia, characteristic for
IP were also found (Figure 2).
A cytogenetic examination yielding normal results
(46, XX), was performed to exclude chromosomal aberra-
tions.
PCR analysis revealed deletion of exons 4–10 in NEMO
gene in the child, but not in any other family member, in-
cluding the mother (Figure 3). Moreover, the child’s
mother has never had any skin or other manifestation
which could indicate IP. Only the infant’s grandmother
has had one spontaneous miscarriage of unknown gen-
der of the fetus. All these findings indicate that de novo
deletion of the NEMO gene appeared in this particular
young girl (Figure 4).
On the basis of the typical hyperpigmentation of
blaschkoid pattern, vesicles and histological examination
as well as the results of PCR analysis, the diagnosis of
incontinentia pigmenti was confirmed.
Discussion
Here we describe a Croatian female with clinical IP
phenotype having de novo genomic rearrangements in
the NEMO gene. Although the mutations of this gene are
ascribed to a familial type of IP, it is obvious that in some
cases the mutation is not inherited.
Skin changes present at birth made this patient hi-
ghly suspective to IP. Clinical manifestations of the skin
appertain to first, inflammatory stage. However, the pa-
thohistological feature of the skin biopsy showed a sec-
ond, progressive verrucose phase of disease, with an ab-
sence of pigment in the basal cells and a large quantity of
melanin in the melanophages in the upper dermis. Such
disproportion between clinical and pathohistological fin-
dings regarding the phase of IP disease, is quite unusual.
Similar data in available literature could not be found.
However, it might be expected that with the course of
time the skin changes will get worse and finally equalize
with pathohistolological findings that will categorize IP
to the second phase of disease.
Genetic testing of diseased child revealed D4–10 in the
NEMO gene, further supporting the clinical diagnosis,
incontinentia pigmenti. However, the assumption that
the female child has familial IP was rejected as the PCR
performed on the mother’s leukocytes did not reveal the
presence of the same mutation as found in the child.
Moreover, the existence of a healthy male infant of the
same mother, as well as the lack of any phenotypic signs
of the disease in other family members additionally sup-
port the conclusion that IP was not inherited, but is a
consequence of de novo NEMO gene mutation.
However, after the final, comprehensive, medical ex-
amine of all family members we can say with noticeable
certainty that the disease was caused by de novo muta-
tion in the NEMO gene typical for familial IP type.
The cause of this de novo mutation is unknown. One
of the possible explanations could be that it was caused
by gene rearrangement during paternal meiosis3. Na-
mely, when IP occurs as a result of de novo mutation, the
mutation usually occurs in the NEMO gene inherited
from the father, just opposite to the inheritance of the
familial form of the disease which is mostly inherited
from the mother.
Some other de novo NEMO gene changes in cases of
sporadic IP, such as frameshift, missense and nonsense
mutations, have been described as well10.
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Fig. 3. Separation of the PCR products by electrophoresis in a 1%
agarose gel. Template DNA are as follows: lanes 1 and 2: blood
DNA from affected child (normal, upper band, at 1186 bp and
the lower, with deleted exons, at 1039 bp); lane 3: unaffected mo-
ther of diseased child (only normal band is present); lane 4: a
known female carrier of NEMO D4–10 (positive control); lanes 5
– 8: four healthy female controls; lane 9: molecular weight marker.
Fig. 4. Pedigree data of the family with de novo NEMO gene
mutation causing IP. I and II – generations; 1, 2, 3 etc. – off-
springs – birth order within generation; I-1, I-3, II-2 – healthy
males; I-4 – healthy females; I-2 – dead female; II-I – 3 sponta-
neous abortions; II-3 (arrow) proband – affected female.
After the disease was proven by genetic testing, the
genetic counseling for the parents was provided. They
were informed about the nature, inheritance, and impli-
cations of this disorder with special emphasis on per-
sonal, cultural, and ethical issues that their child might
face. It was stressed to them that their child descendants
will follow the X linked pattern of heredity i.e, half of the
male conceptuses (those with the mutant ) will be mis-
carried. Thus, at delivery the expected sex ratio of off-
spring will be: 33% females; 33% females; 33% males.
Clinical and pathohistological diagnosis together with
molecular analysis are a part of a conventional procedure
for every congenital skin disorder. In this particular case
the genetic testing, by which the disease was finally
proven, gave the basis for family counseling.
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DE NOVO DELECIJA GENA NEMO (D4–10) – UZROK NASTANKA INCONTINENTIA
PIGMENTI U @ENSKOG DJETETA: PRIKAZ SLU^AJA
S A @ E T A K
Incontinentia pigmenti (IP) je rijetka, nasljedna, multisistemska genodermatoza. Prenosi se kao X-vezano domi-
nantno svojstvo. Bolest je posljedica mutacija gena NEMO (Xq28) koje potpuno dokidaju ekspresiju NF-kappaB. U radu
je prikazan slu~aj `enskog novoro|en~eta (mladih, zdravih roditelja) s klini~ki dokazanom prvom fazom IP. Delecija
gena NEMO (D4–10) dokazana je PCR-analizom DNA izolirane iz perifernih limfocita. Promjene na ko`i vidljive odmah
nakon ro|enja djeteta upu}ivale su na prvu, inflamatornu fazu bolesti. Me|utim, histopatolo{ka analiza bioptata ko`e
pokazala je da se radi o drugoj fazi bolesti. Genetskim testiranjem dokazana je delecija D4–10 u genu NEMO. Me|utim,
pretpostavka da dijete ima naslije|eni, obiteljski oblik IP odba~ena je nakon {to je pokazano da majka ne nosi ovu
mutaciju. Ovo mi{ljenje potkrijepljuje i ~injenica da roditelji bolesne djevoj~ice imaju i zdravo mu{ko dijete, te odsutnost
bilo kakvih fenotipskih znakova bolesti u bilo kojem ~lanu obitelji. Prema tome, u djevoj~ice bolest nije naslije|ena, ve}
je posljedica de novo delecije gena NEMO. U zaklju~ku, u radu opisujemo djevoj~icu sa klini~kim znakovima IP i ge-
netski dokazanim de novo dearan`manom gena NEMO.
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